We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$199M
AUM Growth
-$34.6B
(-99%)
Cap. Flow
-$35.1B
Cap. Flow
% of AUM
-17,587.21%
Top 10 Holdings %
Top 10 Hldgs %
62.92%
Holding
1,077
New
–
Increased
3
Reduced
57
Closed
1,016
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.03M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.53M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.49B |
| 2 |
Microsoft
MSFT
|
+$2.09B |
| 3 |
Apple
AAPL
|
+$1.44B |
| 4 |
Amazon
AMZN
|
+$1.36B |
| 5 |
Meta Platforms (Facebook)
META
|
+$721M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.6% |
| 2 | Consumer Discretionary | 12.36% |
| 3 | Financials | 10.02% |
| 4 | Communication Services | 9% |
| 5 | Healthcare | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Atmos Energy
ATO
$29.7B
| – | – |
-57,944
| Closed | -$8.93M |
|
152
AptarGroup
ATR
$8.69B
| – | – |
-18,678
| Closed | -$2.92M |
|
|
OPTU
153
Optimum Communications Inc
OPTU
$298M
| – | – |
-28,200
| Closed | -$60.3K |
|
154
AngloGold Ashanti
AU
$39.4B
| – | – |
-325,148
| Closed | -$14.8M |
|
|
AUTL
155
Autolus Therapeutics
AUTL
$389M
| – | – |
-3,126,167
| Closed | -$7.13M |
|
156
AvalonBay Communities
AVB
$27.5B
| – | – |
-195,310
| Closed | -$39.7M |
|
157
Broadcom
AVGO
$1.76T
| – | – |
-2,415,767
| Closed | -$666M |
|
158
Avanos Medical
AVNS
| – | – |
-70,277
| Closed | -$860K |
|
159
Avantor
AVTR
$9.82B
| – | – |
-18,933
| Closed | -$255K |
|
160
Avery Dennison
AVY
$12.8B
| – | – |
-2,756
| Closed | -$484K |
|
161
American Water Works
AWK
$27B
| – | – |
-297,318
| Closed | -$41.4M |
|
162
Axos Financial
AX
$5.58B
| – | – |
-84,600
| Closed | -$6.43M |
|
|
AXON
163
Axon Enterprise
AXON
$42.8B
| – | – |
-167,210
| Closed | -$138M |
|
164
AXIS Capital
AXS
$7.81B
| – | – |
-6,138
| Closed | -$637K |
|
165
Axalta
AXTA
$7.45B
| – | – |
-234,145
| Closed | -$6.95M |
|
166
Acuity Brands
AYI
$9.99B
| – | – |
-7,862
| Closed | -$2.35M |
|
|
AZEK
167
DELISTED
The AZEK Co
AZEK
| – | – |
-154,596
| Closed | -$8.4M |
|
168
AstraZeneca
AZN
$269B
| – | – |
-235,592
| Closed | -$32.9M |
|
169
AutoZone
AZO
$51.3B
| – | – |
-7,860
| Closed | -$29.2M |
|
170
Boeing
BA
$169B
| – | – |
-34,655
| Closed | -$7.26M |
|
171
Booz Allen Hamilton
BAH
$8.44B
| – | – |
-27,534
| Closed | -$2.87M |
|
172
Ball Corp
BALL
$17.5B
| – | – |
-15,587
| Closed | -$874K |
|
173
Brookfield Asset Management
BAM
$75.6B
| – | – |
-20,700
| Closed | -$1.14M |
|
174
Credicorp
BAP
$30.5B
| – | – |
-1,740
| Closed | -$389K |
|
175
Baxter International
BAX
$12.8B
| – | – |
-271,156
| Closed | -$8.21M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q3 2025 Portfolio in Review
As of Q3 2025, Axa held 1,077 positions worth $199M, down 99% from $34.8B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Axa withdrew a net $35.1B in Q3 2025, closing 1,016 positions and reducing 57 holdings. Its most notable exit was Broadcom, an estimated $666M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Axa added an estimated $6.03M to iShares Core MSCI Emerging Markets ETF.
- Axa added most to iShares Core MSCI Emerging Markets ETF in Q3 2025, an estimated $6.03M increase.
- Axa's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.49B.
- Axa fully exited Broadcom in Q3 2025, selling an estimated $666M.
- Axa's ten largest holdings make up 63% of its $199M portfolio in Q3 2025.
- Axa opened 0 new positions and closed 1,016 in Q3 2025.
- Axa's portfolio value fell 99% quarter-over-quarter to $199M.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.